Clinical Trial Update: Impact of Hyperbilirubinemia Among HIV Patients Treated With Atazanavir

View source ↗

Summary

This clinical trial update reports the completed study assessing hyperbilirubinemia in HIV patients treated with atazanavir. The emphasis is on safety outcomes …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• REYATAZ (atazanavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV/AIDS | Status: COMPLETED